NURIX THERAPEUTICS, INC. (NRIX) Operating cash flow 2019–2025
NURIX THERAPEUTICS, INC. (NRIX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$249.5MFY2025 · since FY2019: $601,000 → -$249.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$249.5M | -44.5% |
| FY2024 | -$172.6M | -112.1% |
| FY2023 | -$81.4M | +49.1% |
| FY2022 | -$159.8M | -89.4% |
| FY2021 | -$84.4M | -105356.3% |
| FY2020 | -$80,000 | -113.3% |
| FY2019 | $601,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NRIX financial trends
NRIX RevenueNRIX Net incomeNRIX Net marginNRIX Gross profitNRIX Gross marginNRIX Operating incomeNRIX Operating marginNRIX Free cash flowNRIX Capital expendituresNRIX Return on equityNRIX Stock buybacksNRIX Dividends paidNRIX Total assetsNRIX Total liabilitiesNRIX Shareholders’ equityNRIX overview →